4-D (psychedelic): Difference between revisions
Jump to navigation
Jump to search
m Protected "4-D (psychedelic)": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
||
Line 21: | Line 21: | ||
==Reference== | ==Reference== | ||
{{reflist}} | {{reflist|2}} | ||
== See also == | == See also == |
Latest revision as of 13:49, 4 September 2012
4-D | |
---|---|
Chemical name | 3,5-methoxy-4-trideuteromethoxyphenethylamine or 3,5-methoxy-4-trideuteromethoxy-1-ethane |
Chemical formula | C11H14NO3D3 |
Molecular mass | 228.284 b/mol |
SMILES | [2H]C([2H])([2H])Oc1c(OC)cc(cc1OC)CC(N)C |
File:4-D.png File:4-D-3d-sticks.png |
4-D, or 3,5-methoxy-4-trideuteromethoxyphenethylamine, is a lesser-known psychedelic drug. It is one of the only phenethylamines that contains Deuterium, the other being Beta-D. It is also the 4-trideuteromethoxy analogue of 2C-H. It exists as a sulfate salt or a hydrochloride salt. 4-D was first synthesized by Alexander Shulgin. In his book PIHKAL (Phenethylamines I Have Known and Loved), the dosage is listed as approximately 200-400 mg for the sulfate salt, and 178-356 mg for the hydrochloride salt. 4-D lasts for approximately 12 hours. It causes closed-eye visuals, mild open-eye visuals, color distortion, and mydriasis.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of 4-D.